Donanemab (Mouse IgG2a) is a mouse-derived IgG2a monoclonal antibody targeting a specific N-terminal epitope of amyloid-beta associated with Alzheimers disease.
Purity:
95.00%
Target:
Beta Amyloid
* VAT and and shipping costs not included. Errors and price changes excepted